Erythromycin is considered compatible with breastfeeding.
This antibiotic, which could be administered directly to the infant, reaches low concentrations in breast milk, so it is unlikely to cause significant adverse effects on the baby.
As in the case of other antibiotics, can be monitored the occurrence of diarrhea and anal or oral candidiasis.
Some data seem to establish a link between erythromycin given to the mother with the appearance of hypertrophic pyloric stenosis in infants.
Warning of the manufacturer:
Erythromycin is excreted in breast milk, so caution should be exercised with the administration of this drug in women who breastfeed.